Endocrinology

Top Story

Researchers to target receptors for possible exercise pill

May 28, 2017

Researchers at St. Louis University, in St. Louis, Missouri, have received grants to develop a pill that mimics the metabolic effects of exercise, according to a press release from the university.

Thomas Burris, PhD, chair of pharmacology and physiology, and colleagues have received grants from the U.S. Department of Defense and the NIH to study two receptors, REV-ERB and ERR, which in previous study have been suggested as good targets for exercise-mimetic drugs.

Epigenetic modifications may increase obesity risk

May 27, 2017
Researchers have identified a possible association between epigenetic modifications, which control the activity of genes, and increased obesity risk, according to a…
In the Journals Plus

Obesity, diabetes associated with increased risk for severe malaria infection

May 27, 2017
Comorbidity, particularly diabetes, and obesity were significant risk factors for severe infection among nonimmune travelers and immigrants from endemic countries in…
In the Journals Plus

Low 25-(OH)D levels tied to poor glycemic control, more insulin use

May 26, 2017
In adults with type 2 diabetes and chronic kidney disease, lower vs. higher levels of serum 25-hydroxyvitamin D were associated with poorer glycemic control and use of…

Phase 3 data for Romosozumab were favorable for postmenopausal women with osteoporosis

May 26, 2017
Romosozumab met both primary endpoints in the ARCH phase 3 study of postmenopausal women with osteoporosis, according to a company release. “The efficacy results…
More News Headlines »
CME

Practical Lipidology®: Volume 3, Number 2

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Video
Meeting News

VIDEO: Expert identifies new ways to improve profitability

March 2, 2017
More »
Featured
The Endocrine Society Annual Meeting

The Endocrine Society Annual Meeting

CME

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement